Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 5.4B | 5.3B | 5.2B | 4.6B |
Cost of revenue | 3.6B | 3.6B | 3.5B | 3.0B |
Gross profit | 1.9B | 1.8B | 1.7B | 1.6B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 1.0B | 811.4M | 792.9M | 791.2M |
Operating income | 613.3M | 729.1M | 686.8M | 628M |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 247.3M | 269.3M | 279.9M | 198.3M |
Other income expense | — | — | — | — |
Pretax income | 503.9M | 689.4M | 677.2M | 684.1M |
Tax provision | 163.8M | 188.4M | 182M | 173.8M |
Net income | 340.1M | 501M | 495.2M | 510.3M |
Basic EPS | — | 3.3 | 3.3 | 3.4 |
Diluted EPS | — | 3.3 | 3.3 | 3.4 |
Basic average shares | — | 150.5M | 150.5M | 150.5M |
Diluted average shares | — | 150.5M | 150.5M | 150.5M |
EBITDA | 1.1B | 1.2B | 1.2B | 1.1B |
Net income from continuing op. | — | — | — | — |
Minority interests | — | — | — | — |
Preferred stock dividends | 0 | 0 | 0 | 0 |